| Dr Jamie L Buck, MD | |
|
21 Highland Ave Se, Suite 200, Roanoke, VA 24013-2201 | |
| (540) 982-8881 | |
| (540) 982-0442 |
| Full Name | Dr Jamie L Buck |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 18 Years |
| Location | 21 Highland Ave Se, Roanoke, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558540062 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 134280 (North Carolina) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 0101246934 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carilion Medical Center | Roanoke, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mid-atlantic Womens Care Plc | 8820998156 | 140 |
News Archive
When Grace Jividen competed in the 1992 Olympics in Barcelona, Spain, she couldn't hear her opponent's breathing, which she believes could have given her the edge in her judo competitions. Now, the former member of the 1992 U.S. women's judo team and holder of more than 41 medals from international competitions and a sixth degree black belt has the edge she was looking for thanks to Lyric, the world's first 100 percent invisible extended wear hearing device.
UK pet owners who take their animals on holiday to Europe are being alerted to the fact that their pets could bring back some unwelcome souvenirs in the form of diseases more often associated with the tropics.
Using a combination of polymers that respond to temperature, a research team at the University of Utah has developed a multifunctional nanoparticle that can image tumors using ultrasound and simultaneously deliver cell-damaging energy and anticancer drugs to those tumors. In addition, these nanoparticles appear to act specifically on tumors and not on healthy tissue.
Revance Therapeutics, Inc. today announced that the results of two Phase 2b clinical trials on RT001, a topical botulinum toxin type A which is under investigation for the treatment of lateral canthal lines (crow's feet wrinkles) were presented at the annual meeting of the American Society of Dermatologic Surgery in Chicago.
EpiCept Corporation announced today that on February 11, 2010, the Board of Directors of EpiCept Corporation adopted an amendment to the company's Amended and Restated By-Laws to provide that a quorum for the transaction of business at any meeting of the stockholders of the Company shall consist of the holders of one third of the issued and outstanding shares of common stock of the Company.
› Verified 5 days ago
| Entity Name | Mid-atlantic Womens Care Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699365072 PECOS PAC ID: 8820998156 Enrollment ID: O20040115000607 |
News Archive
When Grace Jividen competed in the 1992 Olympics in Barcelona, Spain, she couldn't hear her opponent's breathing, which she believes could have given her the edge in her judo competitions. Now, the former member of the 1992 U.S. women's judo team and holder of more than 41 medals from international competitions and a sixth degree black belt has the edge she was looking for thanks to Lyric, the world's first 100 percent invisible extended wear hearing device.
UK pet owners who take their animals on holiday to Europe are being alerted to the fact that their pets could bring back some unwelcome souvenirs in the form of diseases more often associated with the tropics.
Using a combination of polymers that respond to temperature, a research team at the University of Utah has developed a multifunctional nanoparticle that can image tumors using ultrasound and simultaneously deliver cell-damaging energy and anticancer drugs to those tumors. In addition, these nanoparticles appear to act specifically on tumors and not on healthy tissue.
Revance Therapeutics, Inc. today announced that the results of two Phase 2b clinical trials on RT001, a topical botulinum toxin type A which is under investigation for the treatment of lateral canthal lines (crow's feet wrinkles) were presented at the annual meeting of the American Society of Dermatologic Surgery in Chicago.
EpiCept Corporation announced today that on February 11, 2010, the Board of Directors of EpiCept Corporation adopted an amendment to the company's Amended and Restated By-Laws to provide that a quorum for the transaction of business at any meeting of the stockholders of the Company shall consist of the holders of one third of the issued and outstanding shares of common stock of the Company.
› Verified 5 days ago
| Entity Name | Physicians To Women, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679651715 PECOS PAC ID: 4880657063 Enrollment ID: O20041109000349 |
News Archive
When Grace Jividen competed in the 1992 Olympics in Barcelona, Spain, she couldn't hear her opponent's breathing, which she believes could have given her the edge in her judo competitions. Now, the former member of the 1992 U.S. women's judo team and holder of more than 41 medals from international competitions and a sixth degree black belt has the edge she was looking for thanks to Lyric, the world's first 100 percent invisible extended wear hearing device.
UK pet owners who take their animals on holiday to Europe are being alerted to the fact that their pets could bring back some unwelcome souvenirs in the form of diseases more often associated with the tropics.
Using a combination of polymers that respond to temperature, a research team at the University of Utah has developed a multifunctional nanoparticle that can image tumors using ultrasound and simultaneously deliver cell-damaging energy and anticancer drugs to those tumors. In addition, these nanoparticles appear to act specifically on tumors and not on healthy tissue.
Revance Therapeutics, Inc. today announced that the results of two Phase 2b clinical trials on RT001, a topical botulinum toxin type A which is under investigation for the treatment of lateral canthal lines (crow's feet wrinkles) were presented at the annual meeting of the American Society of Dermatologic Surgery in Chicago.
EpiCept Corporation announced today that on February 11, 2010, the Board of Directors of EpiCept Corporation adopted an amendment to the company's Amended and Restated By-Laws to provide that a quorum for the transaction of business at any meeting of the stockholders of the Company shall consist of the holders of one third of the issued and outstanding shares of common stock of the Company.
› Verified 5 days ago
| Entity Name | Mid-atlantic Womens Care Plc |
|---|---|
| Entity Type | Part B Supplier - Mammography Center |
| Entity Identifiers | NPI Number: 1699365072 PECOS PAC ID: 8820998156 Enrollment ID: O20080611000246 |
News Archive
When Grace Jividen competed in the 1992 Olympics in Barcelona, Spain, she couldn't hear her opponent's breathing, which she believes could have given her the edge in her judo competitions. Now, the former member of the 1992 U.S. women's judo team and holder of more than 41 medals from international competitions and a sixth degree black belt has the edge she was looking for thanks to Lyric, the world's first 100 percent invisible extended wear hearing device.
UK pet owners who take their animals on holiday to Europe are being alerted to the fact that their pets could bring back some unwelcome souvenirs in the form of diseases more often associated with the tropics.
Using a combination of polymers that respond to temperature, a research team at the University of Utah has developed a multifunctional nanoparticle that can image tumors using ultrasound and simultaneously deliver cell-damaging energy and anticancer drugs to those tumors. In addition, these nanoparticles appear to act specifically on tumors and not on healthy tissue.
Revance Therapeutics, Inc. today announced that the results of two Phase 2b clinical trials on RT001, a topical botulinum toxin type A which is under investigation for the treatment of lateral canthal lines (crow's feet wrinkles) were presented at the annual meeting of the American Society of Dermatologic Surgery in Chicago.
EpiCept Corporation announced today that on February 11, 2010, the Board of Directors of EpiCept Corporation adopted an amendment to the company's Amended and Restated By-Laws to provide that a quorum for the transaction of business at any meeting of the stockholders of the Company shall consist of the holders of one third of the issued and outstanding shares of common stock of the Company.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jamie L Buck, MD 21 Highland Ave Se, Suite 200, Roanoke, VA 24013-2201 Ph: (540) 982-8881 | Dr Jamie L Buck, MD 21 Highland Ave Se, Suite 200, Roanoke, VA 24013-2201 Ph: (540) 982-8881 |
News Archive
When Grace Jividen competed in the 1992 Olympics in Barcelona, Spain, she couldn't hear her opponent's breathing, which she believes could have given her the edge in her judo competitions. Now, the former member of the 1992 U.S. women's judo team and holder of more than 41 medals from international competitions and a sixth degree black belt has the edge she was looking for thanks to Lyric, the world's first 100 percent invisible extended wear hearing device.
UK pet owners who take their animals on holiday to Europe are being alerted to the fact that their pets could bring back some unwelcome souvenirs in the form of diseases more often associated with the tropics.
Using a combination of polymers that respond to temperature, a research team at the University of Utah has developed a multifunctional nanoparticle that can image tumors using ultrasound and simultaneously deliver cell-damaging energy and anticancer drugs to those tumors. In addition, these nanoparticles appear to act specifically on tumors and not on healthy tissue.
Revance Therapeutics, Inc. today announced that the results of two Phase 2b clinical trials on RT001, a topical botulinum toxin type A which is under investigation for the treatment of lateral canthal lines (crow's feet wrinkles) were presented at the annual meeting of the American Society of Dermatologic Surgery in Chicago.
EpiCept Corporation announced today that on February 11, 2010, the Board of Directors of EpiCept Corporation adopted an amendment to the company's Amended and Restated By-Laws to provide that a quorum for the transaction of business at any meeting of the stockholders of the Company shall consist of the holders of one third of the issued and outstanding shares of common stock of the Company.
› Verified 5 days ago
Denise Marie Inman, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 21 Highland Ave Se Ste 200, Roanoke, VA 24013 Phone: 540-982-8881 | |
Dr. Shannon Armbruster, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Riverside Cir Ste 300m, Roanoke, VA 24016 Phone: 540-581-0160 | |
Dr. Elizabeth R Martin, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 21 Highland Ave Se, Ste 200, Roanoke, VA 24013 Phone: 540-982-8881 Fax: 540-982-0501 | |
Steven Farber, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 213 Mcclanahan St Sw, Roanoke, VA 24014 Phone: 540-343-1224 | |
Lauren Elizabeth Nelson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 102 Highland Ave Se Ste 303, Roanoke, VA 24013 Phone: 540-985-9715 Fax: 540-985-8487 | |
Caroline Ludwig Welchman, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 21 Highland Ave Se Ste 200, Roanoke, VA 24013 Phone: 540-982-8881 Fax: 540-982-0612 | |
Mark Arner, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 102 Highland Ave Se, Roanoke, VA 24013 Phone: 540-985-9715 Fax: 540-985-9817 |